Abstract:The immunosuppressive status of the tumor microenvironment (TME) remains poorly defined due to a lack of understanding regarding the function of tumor-associated macrophages (TAMs), which are abundant in the TME. TAMs are crucial drivers of tumor progression, metastasis, and resistance to therapy. Intra- and inter-tumoral spatial heterogeneities are potential keys to understanding the relationships between subpopulations of TAMs and their functions. Antitumor M1-like and pro-tumor M2-like TAMs coexist within tumors, and the opposing effects of these M1/M2 subpopulations on tumors directly impact current strategies to improve antitumor immune responses. Recent studies have found significant differences among monocytes or macrophages from distinct tumors, and other investigations have explored the existence of diverse TAM subsets at the molecular level. In this review, we discuss emerging evidence highlighting the redefinition of TAM subpopulations and functions in the TME and the possibility of separating macrophage subsets with distinct functions into antitumor M1-like and pro-tumor M2-like TAMs during the development of tumors. Such redefinition may relate to the differential cellular origin and monocyte and macrophage plasticity or heterogeneity of TAMs, which all potentially impact macrophage biomarkers and our understanding of how the phenotypes of TAMs are dictated by their ontogeny, activation status, and localization. Therefore, the detailed landscape of TAMs must be deciphered with the integration of new technologies, such as multiplexed immunohistochemistry (mIHC), mass cytometry by time-of-flight (CyTOF), single-cell RNA-seq (scRNA-seq), spatial transcriptomics, and systems biology approaches, for analyses of the TME.

Role of the ubiquitin–proteasome system on macrophages in the tumor microenvironment

Roles of Ubiquitination in the Crosstalk Between Tumors and the Tumor Microenvironment (Review)

The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy

Involvement of the ubiquitin-proteasome system in the regulation of the tumor microenvironment and progression

The Ubiquitin–Proteasome System in Tumor Metabolism

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

Research Progress on the Role of Tumor‑associated Macrophages in Tumor Development and Their Use As Molecular Targets (Review).

Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy

From Dichotomy to Diversity: Deciphering the Multifaceted Roles of Tumor-Associated Macrophages in Cancer Progression and Therapy.

The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment

The role of macrophages in the tumor microenvironment and tumor metabolism

The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy

Tumor-associated macrophages: an accomplice in solid tumor progression

Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications

Targeting Tumor-Associated Macrophages in Cancer Immunotherapy

MicroRNAs in Tumor Immunity: Functional Regulation in Tumor-Associated Macrophages.

Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy

Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications

Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment